rosiglitazone has been researched along with Carcinoma, Epidermoid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akanuma, N; Akutsu, Y; Hanari, N; Hoshino, I; Isozaki, Y; Maruyama, T; Matsubara, H; Mori, M; Murakami, K; Nakayama, T; Nishimori, T; Suito, H; Suzuki, A; Takahashi, M; Takeshita, N; Toyozumi, T | 1 |
Horn, TL; Johnson, WD; Lubet, RA; McCormick, DL; Peng, X; Steele, VE | 1 |
Guo, XL; Lu, YY; Wang, HY; Wang, WF; Xin, M; Zhang, Y; Zhou, Y | 1 |
Lou, W; Zhang, J; Zhang, Y | 1 |
4 other study(ies) available for rosiglitazone and Carcinoma, Epidermoid
Article | Year |
---|---|
Screening of alternative drugs to the tumor suppressor miR-375 in esophageal squamous cell carcinoma using the connectivity map.
Topics: Antineoplastic Agents; Apoptosis; Benzocaine; Betazole; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Chenodeoxycholic Acid; Cytotoxins; DNA Primers; Esophageal Neoplasms; Humans; In Situ Nick-End Labeling; Metformin; MicroRNAs; Nizatidine; Organophosphates; Proline; Protein Array Analysis; Real-Time Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Transcriptome; Transfection; Tumor Suppressor Proteins | 2014 |
Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Male; Mouth Neoplasms; Pioglitazone; PPAR gamma; Quinolones; Rats; Rats, Inbred F344; Rosiglitazone; Thiazolidinediones | 2015 |
Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclin B1; Drug Resistance, Neoplasm; G2 Phase Cell Cycle Checkpoints; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; M Phase Cell Cycle Checkpoints; Mouth Neoplasms; Neovascularization, Physiologic; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Polymerization; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tubulin; Vincristine | 2016 |
[Effects of rosiglitazone on the Hep-2 cell proliferation, cell cycle and COX-2 expression].
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Humans; Hypoglycemic Agents; Laryngeal Neoplasms; Rosiglitazone; Thiazolidinediones | 2010 |